InsiderClue
Insiders · Profile

Klein Lawrence Otto

Chief Executive Officer at Oruka Therapeutics · CBO & COO at CRISPR Therapeutics. Filing since 10 Jul 2019. CIK 0001762583

ORKA Oruka Therapeutics, Inc. Chief Executive Officer · 5 trades CRSP CRISPR Therapeutics AG CBO & COO · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ORKA Oruka Therapeutics, Inc.
1 Oct 2026
Chief Executive Officer
Sold on a plan
25,000
$2.09M
2.6%
ORKA Oruka Therapeutics, Inc.
15 Sep 2026
Chief Executive Officer
Sold at will
2,452
$234.68K
0.3%
ORKA Oruka Therapeutics, Inc.
1 Sep 2026
Chief Executive Officer
Sold on a plan
75,000
$6.89M
7.5%
ORKA Oruka Therapeutics, Inc.
15 Jun 2026
Chief Executive Officer
Sold at will
1,729
$120.49K
0.2%
ORKA Oruka Therapeutics, Inc.
16 Mar 2026
Chief Executive Officer
Sold at will
1,729
$71.41K
0.2%
CRSP CRISPR Therapeutics AG
23 Mar 2021
CBO & COO
Sold, plan not stated
100,000
$12.81M
99.0%
CRSP CRISPR Therapeutics AG
15 Jan 2021
CBO & COO
Sold, plan not stated
25,000
$5.38M
55.6%
CRSP CRISPR Therapeutics AG
25 Jun 2020
CBO & COO
Sold, plan not stated
4,912
$369.27K
19.7%
CRSP CRISPR Therapeutics AG
24 Jun 2020
CBO & COO
Sold, plan not stated
65,088
$4.94M
76.5%
CRSP CRISPR Therapeutics AG
11 May 2020
CBO & COO
Sold, plan not stated
25,000
$1.51M
55.6%
CRSP CRISPR Therapeutics AG
11 Jul 2019
Chief Business Officer
Sold, plan not stated
8,421
$421.17K
29.6%
CRSP CRISPR Therapeutics AG
10 Jul 2019
Chief Business Officer
Sold, plan not stated
11,579
$579.18K
36.7%
12 decisions on file.